GEICO 114-O: A randomised phase 2a evaluation of the ATR inhibitor alnodesertib (ART0380) combined with gemcitabine for platinum-resistant high-grade serous ovarian cancer (HGSOC)

International Journal of Gynecological Cancer 2026

View at publisher
Authors: Antonio González-Martı́n, Luís Manso, Alejandro Perez-Fidalgo, María Quindós, Purificación Estévez-García, Sara Pérez-Ramírez, Ana Puertes, Jorge Bartolomé, Maria-Pilar Barretina-Ginesta, Beatriz Pardo, Lydia Gaba, Ana Herrero
+8 more Cinta Hierro, Desirée Headley, Graeme C.M. Smith, Nicola Little, Bryony Harrop, Suraj Menon, Ian C. Smith, Maria Jesus Rubio Pérez
DOI: 10.1016/j.ijgc.2025.103083
Cited by: 0

Fields of Study & Subjects

Ovarian cancer diagnosis and treatment PARP inhibition in cancer therapy BRCA gene mutations in cancer

Publication details

Journal / source
International Journal of Gynecological Cancer
Volume
36
Issue
2
Pages
103083–103083
Publication date
1 February 2026
Language
EN